BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6884427)

  • 1. Selective destruction of the serotonergic fibers of the fornix-fimbria and cingulum bundle increases 5-HT1 but not 5-HT2 receptors in rat midbrain.
    Quik M; Azmitia E
    Eur J Pharmacol; 1983 Jun; 90(4):377-84. PubMed ID: 6884427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regeneration of serotonergic fibers in the rat hypothalamus following unilateral 5,7-dihydroxytryptamine injection.
    Frankfurt M; Azmitia E
    Brain Res; 1984 Apr; 298(2):273-82. PubMed ID: 6609746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5,7-dihydroxytryptamine on HRP retrograde transport from hippocampus to midbrain raphe nuclei in the rat.
    Zhou FC; Azmitia EC
    Brain Res Bull; 1983 Apr; 10(4):445-51. PubMed ID: 6860973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan hydroxylase in hippocampus and midbrain following unilateral injection of 5,7-dihydroxytryptamine.
    Clewans CS; Azmitia E
    Brain Res; 1984 Jul; 307(1-2):125-33. PubMed ID: 6466991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased 5-HT1A receptor immunoreactivity in the rat hippocampus following 5,7-dihydroxytryptamine lesions in the cingulum bundle and fimbria-fornix.
    Patel TD; Azmitia EC; Zhou FC
    Behav Brain Res; 1996; 73(1-2):319-23. PubMed ID: 8788527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal serotonin re-uptake and nocturnal locomotor activity after microinjections of 5,7-DHT in the fornix-fimbria.
    Williams JH; Azmitia EC
    Brain Res; 1981 Feb; 207(1):95-107. PubMed ID: 7470907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
    Butler PD; Pranzatelli MR; Barkai AI
    Brain Res Bull; 1990 Jan; 24(1):125-9. PubMed ID: 2155684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of serotonergic neuronal maturation after fetal mesencephalic raphe transplantation into the 5,7-DHT-lesioned hippocampus of the adult rat.
    Zhou FC; Auerbach SB; Azmitia EC
    Ann N Y Acad Sci; 1987; 495():138-52. PubMed ID: 2886089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced homotypic sprouting of serotonergic fibers in hippocampus. II. An immunocytochemistry study.
    Zhou FC; Azmitia EC
    Brain Res; 1986 May; 373(1-2):337-48. PubMed ID: 3013362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipsilateral alterations in tryptophan hydroxylase activity in rat brain after hypothalamic 5,7-di-hydroxytryptamine lesion.
    Ljubić-Thibal V; Diksic M; Hamel E; Raison S; Pujol JF; Weissmann D
    Brain Res; 1996 Jun; 724(2):222-31. PubMed ID: 8828572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.
    Pazos A; Palacios JM
    Brain Res; 1985 Nov; 346(2):205-30. PubMed ID: 4052776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential response of subtypes of 5-HT1 recognition sites in the rat hippocampus to partial denervation.
    Kiedrowski L; Skangiel-Kramska J; Gradkowska M; Oderfeld-Nowak B
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):213-8. PubMed ID: 2130643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.